Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

NCT05093504 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor's decision for business reasons.

Conditions

Interventions

Sponsor

CytoSorbents, Inc